Session (CTI)

Effective communication about the value of HEOR across functional groups within biopharmaceutical or medical device companies is essential to access adequate resources to support high-quality studies. The objective of the forum is to endow attendees with guidance from experienced industry leaders to identify opportunities for high-value HEOR projects, to determine who the key internal stakeholders are, to effectively sell the value proposition, and to measure and document its impact. Dr. Slejko will start the session, providing a high-level overview of the Women in HEOR Initiative and empirical studies documenting the value of HEOR. Dr. Reed will moderate a discussion with two to three ISPOR member panelists who will share positive and negative lessons learned based on their personal experience in the biopharma-device industry. The goal is for attendees to take away strategies to become more effective advocates for HEOR within their organizations to ensure that adequate funding and other resources are allocated toward high-value research. Attendees will participate in live polling about perceived barriers and facilitators to obtaining buy-in from key internal stakeholders for HEOR studies. Attendees will have the opportunity to ask questions of the panelists.